Zentalis Pharmaceuticals, Inc. (ZNTL) Tops Q3 EPS by 16c

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) reported Q3 EPS of ($0.37), $0.16 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Zentalis Pharmaceuticals, Inc. (ZNTL) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Textron Systems wins $231 million Navy contract for landing craft
• Wendy's U.S. president to resign, company to create COO role